On September 8, 2022 Acorda Therapeutics, Inc. (NASDAQ: ACOR) reported that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12 at 3 p.m. ET (Press release, Acorda Therapeutics, SEP 8, 2022, View Source [SID1234619238]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference will be conducted in a hybrid format, with both in-person and virtual attendees. Acorda’s presentation will be streamed only to registered conference attendees, who will be able to view the presentation live, virtually, and on-demand for 30 days through the H.C. Wainwright Conference Platform.

To register for the in-person or virtual conference, please use the following link: View Source